Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$1.66B |
| 2 |
ORIG
Ocean Rig UDW Inc. Class A Common Shares
ORIG
|
+$1.55B |
| 3 |
RTX Corp
RTX
|
+$664M |
| 4 |
NXP Semiconductors
NXPI
|
+$606M |
| 5 |
Walt Disney
DIS
|
+$528M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RAI
Reynolds American Inc
RAI
|
+$1.46B |
| 2 |
KKR & Co
KKR
|
+$602M |
| 3 |
Meta Platforms (Facebook)
META
|
+$594M |
| 4 |
Mastercard
MA
|
+$560M |
| 5 |
Visa
V
|
+$502M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 30.15% |
| 2 | Technology | 10.69% |
| 3 | Financials | 10.06% |
| 4 | Healthcare | 8.47% |
| 5 | Industrials | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
WBIB
5801
DELISTED
WBI BullBear Value 2000 ETF
WBIB
| $29K | ﹤0.01% |
1,142
+1,122
| +5,610% | +$27.6K |
2017 Q2
1 quarter
|
|
|
EMCG
5802
DELISTED
WisdomTree Emerging Markets Consumer Growth Fund
EMCG
| $29K | ﹤0.01% |
1,158
-6
| -0.5% | -$148 |
2014 Q1
14 quarters
|
|
5803
DELISTED
SUSSEX BANCORP
SBB
| $29K | ﹤0.01% |
1,208
-7,152
| -86% | -$172K |
2013 Q4
15 quarters
|
|
5804
State Street SPDR Russell 1000 Yield Focus ETF
ONEY
$635M
| $28K | ﹤0.01% |
400
| – | – |
2017 Q2
1 quarter
|
|
5805
Redhill Biopharma
RDHL
$4.32M
| $28K | ﹤0.01% |
3
-2
| -40% | -$17.8K |
2017 Q2
1 quarter
|
|
5806
SuperCom
SPCB
$56.2M
| $28K | ﹤0.01% |
40
+20
| +100% | +$12.9K |
2014 Q1
14 quarters
|
|
5807
Colony Bankcorp
CBAN
$418M
| $27K | ﹤0.01% |
1,955
-8
| -0.4% | -$109 |
2013 Q4
15 quarters
|
|
5808
ProShares Trust UltraShort MSCI Emerging Markets
EEV
$3.12M
| $27K | ﹤0.01% |
281
+266
| +1,773% | +$26.7K |
2013 Q3
16 quarters
|
|
5809
First Trust Exchange-Traded Fund II First Trust Indxx Global Natural Resources Income ETF
FTRI
$117M
| $27K | ﹤0.01% |
2,280
-1,150
| -34% | -$13.2K |
2015 Q4
7 quarters
|
|
5810
DELISTED
Nuveen Missouri Quality Municipal Income Fund
NOM
| $27K | ﹤0.01% |
1,798
-1,633
| -48% | -$25.1K |
2013 Q4
15 quarters
|
|
5811
DELISTED
DB Crude Oil Long Exchange Traded Notes due June 1, 2038
OLO
| $27K | ﹤0.01% |
6,000
| – | – |
2015 Q4
7 quarters
|
|
5812
Boston Omaha
BOC
$382M
| $26K | ﹤0.01% |
+1,669
| New | +$23.8K |
2017 Q3
0 quarters
|
|
5813
ClearSign Technologies
CLIR
$17.9M
| $26K | ﹤0.01% |
717
-127
| -15% | -$4.23K |
2013 Q4
15 quarters
|
|
5814
Herzfeld Credit Income Fund
HERZ
$30.7M
| $26K | ﹤0.01% |
464
-457
| -50% | -$25.9K |
2013 Q4
15 quarters
|
|
5815
Global X MSCI Colombia ETF
COLO
$200M
| $26K | ﹤0.01% |
632
-42
| -6% | -$1.7K |
2013 Q4
15 quarters
|
|
5816
Lakeland Industries
LAKE
$92.5M
| $26K | ﹤0.01% |
1,871
-806
| -30% | -$11.8K |
2014 Q3
12 quarters
|
|
5817
Verastem
VSTM
$698M
| $26K | ﹤0.01% |
462
-356
| -44% | -$16.8K |
2013 Q2
17 quarters
|
|
5818
DELISTED
Invesco S&P 500 ex-Rate Sensitive Low Volatility ETF
XRLV
| $26K | ﹤0.01% |
810
-13,783
| -94% | -$428K |
2015 Q2
9 quarters
|
|
5819
DELISTED
Alum Corp of China Ltd
ACH
| $26K | ﹤0.01% |
1,182
+320
| +37% | +$5.61K |
2013 Q2
17 quarters
|
|
|
GFED
5820
DELISTED
Guaranty Federal Bancshares In
GFED
| $26K | ﹤0.01% |
1,228
+251
| +26% | +$5.44K |
2014 Q1
14 quarters
|
|
5821
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $25K | ﹤0.01% |
400
| – | – |
2016 Q3
4 quarters
|
|
5822
Climb Global Solutions
CLMB
$616M
| $25K | ﹤0.01% |
7,300
+4,900
| +204% | +$19.6K |
2013 Q4
15 quarters
|
|
5823
First Capital
FCAP
$207M
| $25K | ﹤0.01% |
717
-8
| -1% | -$262 |
2013 Q4
15 quarters
|
|
5824
GS ActiveBeta US Small Cap Equity ETF
GSSC
$1.03B
| $25K | ﹤0.01% |
+604
| New | +$24.3K |
2017 Q3
0 quarters
|
|
|
VDTH
5825
DELISTED
Videocon d2h Limited
VDTH
| $25K | ﹤0.01% |
2,839
-1,588
| -36% | -$14.6K |
2015 Q2
9 quarters
|
|
Similar funds
Morgan Stanley's Q3 2017 Portfolio in Review
As of Q3 2017, Morgan Stanley held 6,889 positions worth $334B, up 0.86% from $331B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Morgan Stanley's Q3 2017 filing shows 195 new, 3,466 increased, 2,508 reduced and 247 closed positions. Its largest new stake was JBG SMITH: 4,306,383 shares worth $147M. The largest sale was Reynolds American Inc, an estimated $1.46B.
By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, down from 31% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q3 2017 buy was JBG SMITH: 4,306,383 shares worth $147M.
- Morgan Stanley added most to iShares MSCI Emerging Markets ETF in Q3 2017, an estimated $1.66B increase.
- Morgan Stanley's biggest Q3 2017 reduction was KKR & Co, cutting an estimated $602M.
- Morgan Stanley fully exited Reynolds American Inc in Q3 2017, selling an estimated $1.46B.
- Morgan Stanley's ten largest holdings make up 12% of its $334B portfolio in Q3 2017.
- Morgan Stanley opened 195 new positions and closed 247 in Q3 2017.
- Morgan Stanley's portfolio value rose 0.86% quarter-over-quarter to $334B.
Based on Morgan Stanley's 13F filing for Q3 2017, filed 14 Nov 2017.